| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.009 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |